Pyae Phyo SHUN presents a "BUY" recommendation, highlighting rising government support and increasing rates of chronic disease as factors that support Xvivo's growth in the coming years.
Interesting read, thanks Shun! This company seems quite similar to TMDX which drew some attention before the fraud issue happened. Just curious, are you expecting any corrections to occur in the next few quarters?
Interesting read, thanks Shun! This company seems quite similar to TMDX which drew some attention before the fraud issue happened. Just curious, are you expecting any corrections to occur in the next few quarters?